ProPhase Labs, Inc.
PRPH
$0.3288
-$0.0063-1.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.25M | 1.43M | -236.00K | 3.15M | 1.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.25M | 1.43M | -236.00K | 3.15M | 1.50M |
| Cost of Revenue | 513.00K | 905.00K | -466.00K | 3.31M | 1.66M |
| Gross Profit | 734.00K | 526.00K | 230.00K | -165.00K | -155.00K |
| SG&A Expenses | 4.62M | 4.09M | 16.00M | 7.65M | 6.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.14M | 5.09M | 15.60M | 11.08M | 8.73M |
| Operating Income | -3.89M | -3.66M | -15.83M | -7.94M | -7.23M |
| Income Before Tax | -3.69M | -4.68M | -17.40M | -9.10M | -7.75M |
| Income Tax Expenses | 779.00K | -- | 14.56M | -2.51M | -2.29M |
| Earnings from Continuing Operations | -4.47M | -4.68M | -31.95M | -6.59M | -5.46M |
| Earnings from Discontinued Operations | -- | 8.64M | -2.41M | -- | -690.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.47M | 3.97M | -34.36M | -6.59M | -6.15M |
| EBIT | -3.89M | -3.66M | -15.83M | -7.94M | -7.23M |
| EBITDA | -2.55M | -2.18M | -15.18M | -5.55M | -5.69M |
| EPS Basic | -0.11 | 0.11 | -1.59 | -0.35 | -0.33 |
| Normalized Basic EPS | -0.04 | -0.08 | -0.45 | -0.30 | -0.26 |
| EPS Diluted | -0.11 | 0.11 | -1.59 | -0.35 | -0.33 |
| Normalized Diluted EPS | -0.04 | -0.08 | -0.45 | -0.30 | -0.26 |
| Average Basic Shares Outstanding | 41.54M | 35.23M | 20.46M | 19.08M | 18.89M |
| Average Diluted Shares Outstanding | 41.54M | 35.23M | 20.46M | 19.08M | 18.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |